Correction to: Histologic transformation of t(11;18)-positive MALT lymphoma presented with aberrant T-cell marker expression

Correction to: International Journal of Hematology (2020) 111:724–732 https://doi.org/10.1007/s12185-019-02810-y

In the original publication of the article, the “Conflict of Interest” has been published incorrectly. The corrected version is given below.

Conflict of interest: M. Nishikori receives honoraria from Eisai and funding from Eisai and Sumitomo Dainippon Pharmaceutical. A. Takaori-Kondo receives honoraria from Celgene, Bristol-Myers Squibb, Novartis, MSD, Kyowa Kirin, Asteras, and funding from Celgene, Ono, COGNANO, Thyas, Bristol-Myers Squibb, and has research support from Ono, Takeda, Chugai, Eisai, Nippon Shinyaku, Asteras, Kyowa Kirin, Otsuka, Pfizer, Popuri, Ohara, Sanofi, and Kim’s Korean Ginseng. All other authors do not have any conflict of interest to declare.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Momoko Nishikori.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Verify currency and authenticity via CrossMark

Cite this article

Tamura, N., Maeda, H., Nishikori, M. et al. Correction to: Histologic transformation of t(11;18)-positive MALT lymphoma presented with aberrant T-cell marker expression. Int J Hematol (2020). https://doi.org/10.1007/s12185-020-02924-8

Download citation